Ligand Pharmaceuticals
LGND
#4156
Rank
A$3.48 B
Marketcap
$184.49
Share price
-1.28%
Change (1 day)
65.80%
Change (1 year)

EPS for Ligand Pharmaceuticals (LGND)

EPS in 2023 (TTM): $2.36

According to Ligand Pharmaceuticals's latest financial reports the company's current EPS (TTM) is $2.50. In 2022 the company made an earnings per share (EPS) of -$3.15 a decrease over its 2021 EPS that were of $5.51.

EPS history for Ligand Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$2.36-174.89%
2022-$3.15-157.23%
2021$5.51-2571.43%
2020-$0.22-100.46%
2019$48.74353.48%
2018$10.751025%
2017$0.96-700%
2016-$0.16-100.87%
2015$18.411859.32%
2014$0.945.36%
2013$0.898.0704505322479E+18%
2012$0.0000000000-100%
2011$0.78-194.23%
2010-$0.83548.38%
2009-$0.13-98.7%
2008-$9.84-136.52%
2007$26.94-787.8%
2006-$3.92-14.58%
2005-$4.59-21.31%
2004-$5.83-55.15%
2003-$12.9981.33%
2002-$7.172.74%
2001-$6.97-45.93%
2000-$12.90-14.56%
1999-$15.10-45.52%
1998-$27.71-3.97%
1997-$28.85132.31%
1996-$12.42

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$22.53 801.27%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.57-122.93%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.57 122.98%๐Ÿ‡ฌ๐Ÿ‡ง UK
$2.90 16.03%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.96 18.47%๐Ÿ‡บ๐Ÿ‡ธ USA
$8.65 245.81%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.32 152.87%๐Ÿ‡บ๐Ÿ‡ธ USA
$8.15 226.11%๐Ÿ‡บ๐Ÿ‡ธ USA
$22.43 797.15%๐Ÿ‡บ๐Ÿ‡ธ USA